Company / Cash per Share
Xenon Pharmaceuticals Inc. Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.51
FY2025
5-year range
$0.95 / $4.03
FY2021-FY2025
Trend
+37.2%
vs FY2024
Sector context
#85 of 205
Health Care
What the data says
At $2.51, Xenon Pharmaceuticals Inc.'s cash per share ranks #85 of 205 in the Health Care sector. Cash per Share has fluctuated over the past 10 years, ranging from $0.95 in FY2022 to $4.03 in FY2021.
Based on SEC 10-K filings.
2.51 in FY2025 with a 5-year CAGR of +14.0%.
Improved from $2.22 to $2.51 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +38.5%
- 5-Year CAGR
- +14.0%
- 10-Year CAGR
- -
Sector benchmark
#85 of 205 in Health CareTop 41% of 205This company $2.51 Sector average $72.93
▼
-96.6% below sector average
Key checks
Key Insights
- In FY2025, cash per share increased 37.2% year-over-year.
- Ranks #85 out of 205 companies in the Health Care sector.
- Peak cash per share was recorded in FY2021.
- Lowest cash per share in the period was in FY2022.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 3.51 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.51 | +37.2% |
| FY2024 | $1.83 | -17.6% |
| FY2023 | $2.22 | +135.0% |
| FY2022 | $0.95 | -76.5% |
| FY2021 | $4.03 | +209.1% |
| FY2020 | $1.30 | +36.5% |
| FY2019 | $0.95 | -74.6% |
| FY2018 | $3.76 | +294.8% |
| FY2017 | $0.95 | -19.8% |
| FY2016 | $1.19 | -71.3% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026